Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
European Journal of Internal Medicine
|
February 24, 2006
Low-density lipoprotein size and cardiovascular prevention
Manfredi Rizzo, Kaspar Berneis
Diabetes/Metabolism Research and Reviews
|
November 3, 2006
Small, dense low-density-lipoproteins and the metabolic syndrome
Manfredi Rizzo, Kaspar Berneis
International Journal of Cardiology
|
January 18, 2006
Should we measure routinely the LDL peak particle size?
Manfredi Rizzo, Kaspar Berneis
Recent Patents on Cardiovascular Drug Discovery
|
January 29, 2008
An update on the role of the quality of LDL in cardiovascular risk: the contribution of the universities of Palermo and Zurich
Manfredi Rizzo, Kaspar Berneis
Current Medical Research and Opinion
|
May 24, 2007
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates
Manfredi Rizzo, Kaspar Berneis
Cardiovascular Drugs and Therapy
|
June 16, 2006
The clinical relevance of low-density-lipoproteins size modulation by statins
Manfredi Rizzo, Kaspar Berneis
Journal of Atherosclerosis and Thrombosis
|
October 6, 2005
Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention?
Manfredi Rizzo, Kaspar Berneis
Future Cardiology
|
October 7, 2009
Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention
Manfredi Rizzo, Kaspar Berneis
Current Opinion in Clinical Nutrition and Metabolic Care
|
May 24, 2012
Regulation of low-density lipoprotein subfractions by carbohydrates
Philipp A Gerber, Kaspar Berneis
Medical Hypotheses
|
April 29, 2009
Therapy with noninvasive ventilation in patients with obstructive sleep apnoea: effects on atherogenic lipoprotein phenotype
Ruzena Tkacova, Manfredi Rizzo, Kaspar Berneis
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
European Journal of Internal Medicine
|
February 24, 2006
Low-density lipoprotein size and cardiovascular prevention
Manfredi Rizzo, Kaspar Berneis
Diabetes/Metabolism Research and Reviews
|
November 3, 2006
Small, dense low-density-lipoproteins and the metabolic syndrome
Manfredi Rizzo, Kaspar Berneis
International Journal of Cardiology
|
January 18, 2006
Should we measure routinely the LDL peak particle size?
Manfredi Rizzo, Kaspar Berneis
Recent Patents on Cardiovascular Drug Discovery
|
January 29, 2008
An update on the role of the quality of LDL in cardiovascular risk: the contribution of the universities of Palermo and Zurich
Manfredi Rizzo, Kaspar Berneis
Current Medical Research and Opinion
|
May 24, 2007
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates
Manfredi Rizzo, Kaspar Berneis
Cardiovascular Drugs and Therapy
|
June 16, 2006
The clinical relevance of low-density-lipoproteins size modulation by statins
Manfredi Rizzo, Kaspar Berneis
Journal of Atherosclerosis and Thrombosis
|
October 6, 2005
Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention?
Manfredi Rizzo, Kaspar Berneis
Future Cardiology
|
October 7, 2009
Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention
Manfredi Rizzo, Kaspar Berneis
Current Opinion in Clinical Nutrition and Metabolic Care
|
May 24, 2012
Regulation of low-density lipoprotein subfractions by carbohydrates
Philipp A Gerber, Kaspar Berneis
Medical Hypotheses
|
April 29, 2009
Therapy with noninvasive ventilation in patients with obstructive sleep apnoea: effects on atherogenic lipoprotein phenotype
Ruzena Tkacova, Manfredi Rizzo, Kaspar Berneis
Page
of 6